Schonfeld Strategic Advisors LLC 13D and 13G filings for Reviva Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:16 pm Sale |
2024-12-31 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Schonfeld Strategic Advisors LLC | 1,314,915 2.820% |
-457,800 (-25.82%) |
Filing |
| 2024-11-14 4:15 pm Purchase |
2024-09-30 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Schonfeld Strategic Advisors LLC | 1,772,715 5.300% |
1,772,715 (New Position) |
Filing |